Modulating BCL11A levels and DNA binding to control fetal hemoglobin production in adult-like HUDEP-2 cells
BCL11A is a pleiotropic transcription factor required for neurodevelopment, hematopoiesis, and the fetal-to-adult hemoglobin switch. Its erythroid-specific activity is a major therapeutic target for sickle cell disease and β-thalassemia. We investigate BCL11A function and regulation through three complementary approaches. First, we show that BCL11A ZF2-3 and ZF4-6 zinc-finger arrays recognize related 6-bp TGnCCA motifs through distinct strand-specific interactions, supporting a model in which BCL11A oligomers engage multiple DNA motifs. Second, we demonstrate that small-molecule inhibitors targeting DNA methylation, H3K9 methylation, or H3K27 methylation increase fetal hemoglobin (HbF) expression in HUDEP-2 cells, with low-dose combinations producing synergistic effects. The H3K27 methylation inhibitor FTX6058 also reduces BCL11A expression, potentially through LIN28B activation. Third, screening 213 molecular glue degraders identifies compounds that promote degradation of the zinc-finger proteins IKZF1 and ZFP91 and induce HbF expression. Together, these findings define multiple regulatory mechanisms and complementary pharmacological strategies for HbF reactivation.
Authors
- John R. Horton (ORCID: https://orcid.org/0000-0001-9749-8068)
- Gianluca Sbardella (ORCID: https://orcid.org/0000-0003-0748-1145)
- Xiaodong Cheng (ORCID: https://orcid.org/0000-0002-6967-6362)
- Marcos R. Estecio (ORCID: https://orcid.org/0000-0002-6874-7413)
- Polina A. Iakova (ORCID: https://orcid.org/0000-0003-2658-7252)
- Robert Blumenthal (ORCID: https://orcid.org/0000-0002-0873-0724)
- Yue Lu (ORCID: https://orcid.org/0009-0004-5465-367X)
- Han Xu (ORCID: https://orcid.org/0000-0002-8654-461X)
- Puspa Das
- Jian Jin
- Jiahua Wang (ORCID: https://orcid.org/0009-0009-1171-4125)
- Meigen Yu
- Jujun Zhou
- Wei He
- Tingting Hong
- Abhinav K. Jain
- Xing Zhang
- Yun Huang
- Yan Xiong
- Jisun Lee
- Rongjie Fu
Institutions
- University of Salerno (IT)
- The University of Texas MD Anderson Cancer Center (US)
- Tisch Cancer Institute (US)
- University of Toledo (US)
- Texas A&M University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1016/j.celrep.2026.118340
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Energy
- Cancer Prevention and Research Institute of Texas
- York University
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. National Library of Medicine
- Brookhaven National Laboratory